Elevated circulating CT-1 levels have been observed in humans with obesity [7,8], metabolic syndrome (MetS) [8] and type 2 diabetes (T2DM) [9], suggesting that CT-1 may play a pathophysiological role in obesity-related complications. Here, CTF1 is linked to obesity disorder.